Michaela A. Dinan, PhD
Michaela A. Dinan, PhD, has been appointed Co-Leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, beginning January 1, 2021. Dr. Dinan was also named Associate Professor in the Department of Chronic Disease Epidemiology at the Yale School of Public Health and will also be a core faculty member of the Cancer Outcomes, Public Policy, and Effectiveness Research Center at Yale.
“Dr. Dinan will be an integral member of the Yale Cancer Center leadership team and will undoubtedly make a profound impact on the great research from our Cancer Prevention and Control Research Program and our Cancer Center,” said Charles Fuchs, MD, MPH, Director of the Yale Cancer Center and Physician-in-Chief at Smilow Cancer Hospital.
Charles Fuchs, MD, MPH
Melinda Irwin, PhD
“I look forward to working closely with Dr. Dinan,” said Melinda Irwin, PhD, Associate Director for Population Sciences at the Yale Cancer Center. “She, along with Cancer Prevention and Control Co-Leader Xiaomei Ma, PhD, will help advance our mission to identify the causes of human cancers; assess patterns of care received by patients with cancer; and then to develop social, behavioral, and therapeutic approaches to translate these findings into public health interventions to reduce cancer incidence, morbidity, and mortality.”
Professional Experience
Dr. Dinan joins the Yale Cancer Center from Duke Cancer Institute/Duke Clinical Research Institute, where she was Associate Professor in the Department of Population Health Sciences within the Department of Medicine, Medical Oncology and also co-led the Patient Experience and Survivorship Focus Area in the Cancer Control and Population Sciences Program. She received her undergraduate degree from the University of Virginia in biology and her PhD from the University of North Carolina at Chapel Hill in health policy and management.
